Cingulate Amends Agreement Extending CMO's Trial Period

Cingulate amended Matthew Brams' employment agreement, extending his trial period through September 30, 2026. The update sets the Chief Medical Officer's base salary to $400,000 and permits the CEO to determine his future full-time or part-time status post-extension.